Mkts

Madrigal Pharmaceuticals, Inc.

NASDAQ: MDGL
$431.15+0.80 (+0.18%)
As of Nov 2, 4:00 PM ET

Key statistics

Day range
425.33436.74
52-week range
399.00615.00
Today
Open430.04
Previous close431.15
Volume—
Valuation
Market cap9.94B
P/E ratio—
EPS (TTM)-12.87
Income & risk
Dividend / yield—
Beta-1.05
Avg volume321.7K
Discussion

MDGL News

Stories mentioning MDGL from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue311,337321,083287,268212,802137,250103,32062,17514,638
Cost of Goods Sold4,513
Gross Profit132,737
Operating Expenses
Research & Development
Sales General & Admin268,521239,976209,117196,858167,876141,224107,585105,448
Total Operating Expenses404,060380,692401,243260,004216,561170,317178,479177,175
Operating Income (Loss)(92,723)(59,609)(113,975)(47,202)(79,311)(66,997)(116,304)(162,537)
Interest Income8,2439,45910,3088,2279,37011,07913,01914,222
Interest Expense3,2973,6793,656
Other Expense(2,092)(128.00)(293.00)(42.00)0.000.000.00
Pretax Income
Tax Provision
Net Income (Loss)(94,391)(58,575)(114,190)(42,281)(73,238)(59,416)(106,964)(151,971)
Earnings Per Share (Basic)(3.25)(2.61)(4.01)(1.50)(2.61)(2.79)(4.92)(7.10)
Earnings Per Share (Diluted)(3.25)(2.61)(4.01)(1.50)(2.61)(2.79)(4.92)(7.10)
Weighted Average Shares Outstanding (Basic)29,03222,43428,50828,23328,08521,27321,74621,403
Weighted Average Shares Outstanding (Diluted)29,03222,43428,50828,23328,08521,27321,74621,403

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About MDGL

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is a stock listed on the Nasdaq Stock Market under the ticker symbol MDGL. It last traded at $431.15 (Nov 2, 2026, 4:00 PM ET), up 0.2% on the day. That gives Madrigal Pharmaceuticals a market capitalisation of $9.9B.

Over the past 52 weeks MDGL has traded between $399.00 and $615.00.

Revenue for the quarter ended Mar 31, 2026 was $311.3M; a net loss of $94.4M. Revenue was up 127% from $137.3M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$311.3M-$94.4M-30.3%
Dec 31, 2025$321.1M-$58.6M-18.2%
Sep 30, 2025$287.3M-$114.2M-39.8%
Jun 30, 2025$212.8M-$42.3M-19.9%

From Madrigal Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…